May 2024Sex differences in odds of brain metastasis and outcomes by brain metastasis status after advanced melanoma diagnosisSkin cancer
October 2022Systemic anticancer therapy at the end of life—changes in usage pattern in the immunotherapy eraSkin cancerLung cancerReal-World DataBladder cancerTreatment and Testing patterns
April 2022Analysis of a real-world progression variable and related endpoints for patients with five different cancer typesMethodologyBreast cancerKidney cancerSkin cancerLung cancerReal-World DataGastric cancer
October 2020Organ dysfunction in advanced melanoma patients treated with immune checkpoint inhibitorsUnmet needRegulatorySkin cancerReal-World DataTreatment and Testing patterns
July 2020Adoption of immune checkpoint inhibitors and patterns of care at the end of lifeColorectal cancerSkin cancerLung cancerReal-World DataTreatment and Testing patterns
September 2019Association of programmed cell death 1 (PD-1) inhibitor therapy with overall survival (OS) in stage IV melanoma treated with targeted therapiesComparative effectivenessSkin cancer
June 2019Affordable Care Act Medicaid expansion impact on racial disparities in time to cancer treatmentHealth equityBreast cancerSkin cancerLung cancer
June 2019Organ dysfunction and clinical outcomes in patients treated with immune checkpoint inhibitorsUnmet needHead and neck cancerKidney cancerSkin cancerLung cancerGastric cancer
May 2019Cost-effectiveness of multi-gene panel sequencing for patients with advanced melanomaSkin cancer